Zobrazeno 1 - 10 of 35 pro vyhledávání: '"M J, Ackerman"'
1
In vivo KCNQ1-suppression-replacement gene therapy in transgenic rabbits with type 1 long QT syndrome
Autor: L Giammarino, S Nimani, S Bains, N Alerni, D J Tester, N Christoforou, J Louradour, J Jurgensen, M A Barry, G Koren, M Zehender, M Brunner, G Brooks, M J Ackerman, K E Odening
Publikováno v: Europace. 25
Funding Acknowledgements Type of funding sources: Private company. Main funding source(s): Pfizer Background Type 1 long QT syndrome (LQT1) is a genetic channelopathy characterized by both haploinsufficient and dominant-negative loss-of-function path
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::113b06ff67dbeac34196341fb5b04d85
https://doi.org/10.1093/europace/euad122.594
Zobrazit plný text záznamu
2
Ventricular conduction is a marker for arrhythmic risk in overlap sodium channel disease
Autor: Y Wijeyeratne, M W Tanck, P P Mckeown, V Probst, L Crotti, S Page, J Galvin, E Petzer, M Horie, D Roden, C Veltmann, N Makita, T Aiba, M J Ackerman, E R Behr
Publikováno v: Europace. 25
Funding Acknowledgements Type of funding sources: Public Institution(s). Main funding source(s): National Institute of Health Research St George's, University of London Background SCN5A-E1784K (c.5350G>A) is the most common variant associated with th
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4a130f3b97324a3fc5282844892562d6
https://doi.org/10.1093/europace/euad122.280
Zobrazit plný text záznamu
3
Flecainide is associated with a reduction in arrhythmic events in a large cohort of patients with catecholaminergic polymorphic ventricular tachycardia
Autor: A T Bergeman, M W Tanck, D Kallas, S Sanatani, A Leenhardt, M J Ackerman, J Till, E Zorio, P J Kannankeril, J A E Kammeraad, T Aiba, C Semsarian, T Robyns, A A M Wilde, C Van Der Werf
Publikováno v: Europace. 25
Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): This work was supported by the ZonMW Priority Medicines for Rare Diseases and Orphan Drugs (grant 113304045 to Dr Van der Werf) and th
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5a2fdd81960d2956a002e53c2553a535
https://doi.org/10.1093/europace/euad122.301
Zobrazit plný text záznamu
5
Oral abstract presentations & Young Investigators Competition
Autor: A. Leone, I. Aquila, C. Vicinanza, C. Iaconetti, A. Bochicchio, S. Ottolenghi, C. Indolfi, B. Nadal-Ginard, G. M. Ellison, D. Torella, C. Mias, G. Genet, C. Guilbeau-Frugier, A. Pathak, J. M. Senard, C. Gales, A. D. Egorova, P. S. J. Khedoe, M. T. H. Goumans, S. M. Nauli, P. Ten Dijke, R. E. Poelmann, B. P. Hierck, M. Miragoli, M. J. Lab, A. Singh, M. Sikkel, A. Lyon, J. Gorelik, C. Cheung, A. S. Bernardo, M. W. Trotter, R. A. Pedersen, S. Sinha, M. Mioulane, G. Foldes, S. E. Harding, B. Reglin, T. W. Secomb, A. R. Pries, M. Buckingham, F. Lescroart, S. Meilhac, J.-F. Le Garrec, N. Rozmaritsa, T. Christ, E. Wettwer, M. Knaut, U. Ravens, S. Tokar, S. Schobesberger, P. T. Wright, A. R. Lyon, A. Van Mil, S. Grundmann, M.-J. Goumans, S. Jaksani, P. A. Doevendans, J. P. Sluijter, A. J. Tijsen, A. S. Amin, J. R. Giudicessi, M. W. Tanck, C. R. Bezzina, E. E. Creemers, A. M. Wilde, M. J. Ackerman, Y. M. Pinto, C. Gedicke-Hornung, V. Behrens-Gawlik, D. Khajetoorians, G. Mearini, S. Reischmann, B. Geertz, T. Voit, P. Dreyfus, T. Eschenhagen, L. Carrier, G. D. Duerr, J. C. Heinemann, D. Wenzel, A. Ghanem, J. C. Alferink, A. Zimmer, B. Lutz, A. Welz, B. K. Fleischmann, O. Dewald, M. Sbroggio', A. Bertero, L. Giuliano, M. Brancaccio, G. Tarone, M. Meiser, M. Kohlhaas, Y. Chen, G. Csordas, G. Dorn, C. Maack, B. Stapel, M. Hoch, A. Haghikia, P. Fischer, D. Hilfiker-Kleiner, B. Schroen, M. Corsten, W. Verhesen, L. De Windt, S. Zacchigna, T. Thum, P. Carmeliet, A. Papageorgiou, S. Heymans, I. G. Lunde, A. V. Finsen, G. Florholmen, B. Skrbic, H. Kvaloy, H. O. Jarstadmarken, I. Sjaastad, T. Tonnessen, C. R. Carlson, G. Christensen, J. Paavola, S. Schliffke, S. Rossetti, I. Kuo, S. Yuan, Z. Sun, P. Harris, V. Torres, B. Ehrlich, P. Robinson, K. Adams, Y.-H. Zhang, B. Casadei, H. Watkins, C. Redwood, A. N. Seneviratne, J. E. Cole, M. E. Goddard, Z. Mohri, A. J. Cross, R. Krams, C. Monaco, B. R. Everaert, S. J. Van Laere, V. Y. Hoymans, J. P. Timmermans, C. J. Vrints
Publikováno v: Cardiovascular Research. 93:S46-S51
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4a52b77941d9905cf8e4ee33f2cbdeb8
https://doi.org/10.1093/cvr/cvr333
Zobrazit plný text záznamu
6
The Visible Human Project
Autor: M J Ackerman
Publikováno v: Proceedings of the IEEE. 86:504-511
The Visible Human Project data sets are designed to serve as a common reference point for the study of human anatomy, as a set of common public-domain data for testing medical imaging algorithms, and as a testbed and model for the construction of ima
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d9294faba9b59ee7e161a3165646c51c
https://doi.org/10.1109/5.662875
Zobrazit plný text záznamu
10
Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome
Autor: M J, Ackerman, B L, Siu, W Q, Sturner, D J, Tester, C R, Valdivia, J C, Makielski, J A, Towbin
Publikováno v: JAMA. 286(18)
Fatal arrhythmias from occult long QT syndrome may be responsible for some cases of sudden infant death syndrome (SIDS). Because patients who have long QT syndrome with sodium channel gene (SCN5A) defects have an increased frequency of cardiac events
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0bce0dba4114dad106151d2cc8f5fdee
https://pubmed.ncbi.nlm.nih.gov/11710892
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje